MAPT and Alzheimer disease: Additionally, the behavioral tests confirmed a therapeutic effect shortly after vaccination and at later stages, which was especially pronounced the vaccine containing the phospho-tau epitope Tau[pS202/pT205], reflecting a rather late phosphorylation event in AD.